Bergan, Marie Burns
Larsen, Marthe
Moshina, Nataliia
Bartsch, Hauke
Koch, Henrik Wethe
Aase, Hildegunn Siv
Satybaldinov, Zhanbolat
Haldorsen, Ingfrid Helene Salvesen
Lee, Christoph I.
Hofvind, Solveig http://orcid.org/0000-0003-0178-8939
Funding for this research was provided by:
Kreftforeningen (214931)
Norwegian Institute of Public Health
Article History
Received: 25 September 2023
Revised: 19 January 2024
Accepted: 10 February 2024
First Online: 25 March 2024
Declarations
:
: The scientific guarantor of this publication is Solveig Hofvind.
: The authors declare no competing interests.
: One of the authors (ML) has significant statistical expertise, but no complex statistical methods were necessary for this paper.
: The study was approved by the Regional Committees for Medical and Health Research Ethics (#13294) and had a legal basis in accordance with Articles 6 (1) (e) and 9 (2) (j) of the GDPR. Pursuant to Section 35 of the Health Research Act, the Regional Committees for Medical Research Ethics has granted the project exemption from the requirement of consent.
: Institutional review board approval was obtained. The study was approved by the Regional Committee for Medical and Health Research Ethics (#2018/2574).
: A retrospective study using a cancer-enriched sample from Rogaland, 2010–2018, has been published (Koch HW, Larsen M, Bartsch H, Kurz KD, Hofvind S (2023) Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases. Eur Radiol 33:3735–3743). This study uses data from a regular screening setting in Rogaland, 2017–2019, so there are some overlapping examinations from 2017 and 2018.
: • retrospective• registry study/observational study• performed at two breast centers